Up-regulation of glucosylceramide synthase in urinary bladder neoplasms

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 4, 2012, Pages 444-449

  Sun, Chang cheng ^a   Zhang, Zhe ^a   Zhang, Si Yang ^a   Li, Jun ^a   Li, Ze liang ^a   Kong, Chui ze ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Bladder neoplasms; Clinicopathologic features; Glucosylceramide synthase (GCS); Prognosis

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; UPREGULATION;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; FEMALE; GLUCOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84863004914     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.04.012     Document Type: Article

References (22)

1. Parkin D.M., Pisani P., Ferlay J. Global Cancer Statistics. CA Cancer J Clin 1999, 49:33-64.
2. Shipley W.U., Kaufman D.S., Tester W.J., et al. An overview of bladder cancer trials in the Radiation Therapy Oncology Group (RTOG). Cancer 2003, 97(8 Suppl):2115-2119.
3. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer. Urol 2002, 60:62-68.
4. Zietman A.L., Grocela J., Zehr E., et al. Selective bladder conservation using transurethral resection, chemotherapy and radiation: The management and consequences of Ta, T1, Tis recurrence within the retained bladder. Urology 2001, 58:380-385.
5. Carpinteiro A., Dumitru C., Schenck M., et al. Ceramide-induced cell death in malignant cells. Cancer Lett 2008, 264:1-10.
6. Alphonse G., Bionda C., Aloy M.T., et al. Overcoming resistance to γ-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels. Oncogene 2004, 23:2703-2715.
7. Liu Y.Y., Yu J.Y., Yin D., et al. A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J 2008, 22:2541-2551.
8. Gouazé-Andersson V., Yu J.Y., Kreitenberg A.J., et al. Ceramide and glucosylceramide up-regulate expression of the multidrug resistance gene MDR1 in cancer cells. Biochim Biophys Acta 2007, 1771:1407-1417.
9. Xie P., Shen Y.F., Shi Y.P., et al. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res 2008, 32:475-480.
10. Liu Y.Y., Han T.Y., Giuliano A.E., et al. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 1999, 274:1140-1146.
11. Lucci A., Cho W.I., Han T.Y., et al. Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res 1998, 18:475-480.
12. Jeckel D., Karrenbauer A., Burger K.N., et al. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol 1992, 117:259-267.
13. Yong-yu Liu, Tie-yan Han, Armando E., et al. Ceramide glycosylation potentiates cellular multidrug resistance. The FASEB J 2001, 15:719-730.
14. Gouaze V., Liu Y.Y., Prickett C.S., et al. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res 2005, 65:3861-3867.
15. Gouazé-Andersson V., Yu J.Y., Kreitenberg A.J., et al. Ceramide and glucosylceramide up-regulate expression of the multidrug resistance gene MDR1 in cancer cells. Biochim Biophys Acta 2007, 1771:1407-1417.
16. Marks D.L., Wu K., Paul P.Y., et al. Oligomerization and topology of the Golgi membrane protein glucosylceramide synthase. J Biol Chem 1999, 274:451-456.
17. Jeckel D., Karrenbauer A., Burger K.N., et al. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol 1992, 117:259-267.
18. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
19. Hakomori S., Handa K., Iwabuchi K., et al. New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Glycobiology 1998, 8:11-19.
20. Liu Y.Y., Han T.Y., Giuliano A.E., et al. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-α induced apoptosis. Exp Cell Res 1999, 252:464-470.
21. Lachmann R.H. Miglustat Oxford GlycoSciences/Actelion. Curr Opin Invest Drugs 2003, 4:472-479.
22. Deng W., Li R., Ladisch S. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst 2000, 92:912-917.